Skip to content

Impact of Systematic Tracking of Dementia Cases on the Rate of Hospitalization in Emergency Care Units

Interest of Systematic Tracking of Dementia Cases in Nursing Homes: Analysing the Contribution of MultiDisciplinary Team Meeting (MDTM) in Alzheimer's Disease and Related Diseases

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01569997
Acronym
IDEM
Enrollment
1428
Registered
2012-04-04
Start date
2010-05-31
Completion date
2013-09-30
Last updated
2020-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia in Nursing Home

Keywords

Dementia, emergency hospitalization, nursing home, multidisciplinary meeting, cognitive decline, disability, residents, facilities, long term care unit, health policy, general practitioner, prevention

Brief summary

Introduction: Epidemiological data show that in France only half of patients with Alzheimer disease are currently diagnosed in the general population. The absence of early diagnosis of dementia reduces the opportunities of patients to receive optimal care. One of the consequences of undiagnosed dementia is inadequate use of emergency care units. The main objective: The main aim of this study is to evaluate the impact of a systematic case-finding procedure of dementia cases in nursing homes through a MDTM on the rate of hospitalization in emergency care units. Secondary objectives: To assess the impact of systematic tracking of dementia cases on the: * Quantity and quality of drug-prescription * Appropriateness of hospitalizations * Prevalence of neuropsychiatric symptoms * Dependency * Quality of life * Burden of nursing staff working conditions * Planning of specific therapeutic measures * Overall health care costs

Detailed description

This is a multicentre, cluster randomized study comparing two parallel groups: * Intervention group: nursing homes whose residents benefit from MDTM to identify the cases of dementia and to propose an adequate care project * Control group: nursing homes whose residents continue to benefit from usual care In each group, 1000 elderly subjects aged over 60 years without documented diagnosis of dementia will be included and monitored for a period of 18 months. Information about the main and secondary aims will be collected monthly through online questionnaires.

Interventions

OTHERMultiDisciplinary Team Meetings (MDTM)

The MDTM, between the memory experts and Nursing Home coordinating practitioners, could help the nursing home medical staff identify the cases of dementia and propose these residents an adequate healthcare project (supplementary investigations, therapeutic modifications, hospitalizations...)

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Residents of both sex, aged 60 years or over * Residents living in a nursing home participating in the study * Residents living in the nursing home for 30 days or more * Residents without diagnosed and documented dementia, identified as follows: * residents not identified by the French Healthcare system as suffering from dementia (ALD 15) * residents not benefiting from a specific care program or a specialized follow-up for dementia * residents for whom there is no appropriate investigation for dementia diagnosis in medical records * residents not taking specific drugs for dementia (Cholinesterase inhibitors and/or Memantine) * Residents and their GP having received information about the study * Residents and their GP having expressed their agreement to participate in the study

Exclusion criteria

* Residents aged less than 60 years * Residents not living in a nursing home participating in study * Residents living in nursing home for less than 30 days * Residents with diagnosed and documented dementia, identified as follows: * residents Identified by the French Healthcare system as suffering from dementia (ALD 15) * residents benefiting from specific care programme or specialized follow-up for dementia * residents for whom there is appropriate investigation for dementia diagnosis in medical records * residents taking specific drugs for dementia (Cholinesterase inhibitors and/or Memantine) * Residents and/or their GP who received no information about the study * Residents and/or their GP having expressed their opposition to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Incidence of hospitalizations in emergency care units18 monthsMonthly collection during follow-up (18 months)

Secondary

MeasureTime frameDescription
Number of nursing staff's time off work18 monthsMonthly collection during follow-up (18 months)
Prevalence of antipsychotic prescriptionBaseline visit, 4 months, 18 months
Incidence of inappropriate hospitalizations18 monthsMonthly collection during follow-up (18 months)
Prevalence of neuropsychiatric symptoms evaluated by NPI-nursing staff versionBaseline visit, 18 months
Number of days off work by nursing staff18 monthsMonthly collection during follow-up (18 months)
Quality of life evaluated by QOL-ADBaseline visit, 18 months
Presence of advanced care planning in patients medical recordsBaseline visit, 18 monthsAdvanced care planning will be checked through behavioural disosders, transfer to hospital intensive care and resuscitation
Overall healthcare costs18 monthsMonthly collection during follow-up (18 months)
Dependency evaluated by AGGIR and IADL-4 itemsBaseline visit, 18 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026